Literature DB >> 2844443

The cortisol response to corticotrophin-releasing factor is blunted in obesity.

P G Kopelman1, A Grossman, P Lavender, G M Besser, L H Rees, D Coy.   

Abstract

Abnormalities of the adrenal cortex may be associated with extreme obesity but there is little information about hypothalamic-pituitary function. We have investigated this by measuring plasma ACTH and cortisol responses to ovine corticotrophin releasing factor (CRF-41), 0.5 microgram/kg/body weight, in 10 obese women and seven age-matched normal weight women. The cortisol response to insulin-induced hypoglycaemia and intravenous synacthen (2.5 ng/kg/body weight) were also measured on different occasions in some of the subjects. The peak ACTH response to CRF was less in the obese but this was not significant (obese ACTH +/- SEM, 31 +/- 4 ng/l, controls 39 +/- 4 ng/l) whereas the peak cortisol was significantly reduced in the obese (obese cortisol, 456 +/- 21 nmol/l, controls 638 +/- 50 nmol/l). Doubling the dose of CRF did not significantly alter either ACTH or cortisol responses in six of the obese patients. The peak cortisol response to symptomatic hypoglycaemia and following i.v. low dose synacthen stimulation was similar in the obese and normal weight women. We conclude that obese women have a normal cortisol response to hypothalamic-pituitary stimulation by hypoglycaemia and direct adrenal stimulation by synacthen but an impaired adrenal response to pituitary stimulation with CRF. Although the explanation for these findings is uncertain, our study underlines the importance of considering an individual's body weight when assessing the cortisol response to CRF stimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844443     DOI: 10.1111/j.1365-2265.1988.tb01197.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people.

Authors:  M L Drent; H J Adèr; E A van der Veen
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

2.  Impact of Adiposity and Fat Distribution on the Dynamics of Adrenocorticotropin and Cortisol Rhythms.

Authors:  Ferdinand Roelfsema; Alberto M Pereira; Johannes D Veldhuis
Journal:  Curr Obes Rep       Date:  2014-12

3.  Comparison of the effects of the L-dopa and insulin tolerance tests on cortisol secretion.

Authors:  S Acar; A Paketçi; H Tuhan; K Demir; E Böber; A Abaci
Journal:  J Endocrinol Invest       Date:  2018-01-20       Impact factor: 4.256

4.  Effect of fenfluramine on prolactin and thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in obese and normal women.

Authors:  G Argenio; G Bernini; M S Vivaldi; C Del Corso; F Monzani; L Baschieri; G Bertolozzi; R Santoni; F Franchi; M Luisi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Altered response to neuroendocrine challenge linked to indices of the metabolic syndrome in healthy adults.

Authors:  A R Tyrka; O C Walters; L H Price; G M Anderson; L L Carpenter
Journal:  Horm Metab Res       Date:  2012-04-27       Impact factor: 2.936

6.  Interaction of the hypothalamo-hypophyseal-adrenal and peptidergic systems of the hypothalamus in animals with experimental diabetes mellitus.

Authors:  A V Abramov; O V Mel'nikova
Journal:  Neurosci Behav Physiol       Date:  1997 Jan-Feb

7.  Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index.

Authors:  Johannes D Veldhuis; Ferdinand Roelfsema; Ali Iranmanesh; Bernard J Carroll; Daniel M Keenan; Steven M Pincus
Journal:  J Clin Endocrinol Metab       Date:  2009-09-15       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.